Introduction
In 1963, a nationwide registry of gastric cancer patients was launched by the Japanese Research Society for Gastric Cancer. The society was reorganized into the Japanese Gastric Cancer Association (JGCA) in 1997, but the data collection has been continued by the new association. Requirements to participate in the activity were strict: leading national or regional hospitals having full-time specialists of diagnosis, surgery, and pathology, and 90% and more follow-up rate. In the period , data were collected and analyzed. The re-
Materials and methods
In 1989, the registration committee of the Japanese Research Society for Gastric Cancer started to design and organize a personal computer registration system for patients with gastric cancer. The committee had to produce four programs for different computer operation systems: MS-DOS Basic, FileMaker Pro for Windows, FileMaker Pro for Macintosh, and a special database system sold in the Japanese market. Each member hospital selected an appropriate program for its computer. In 1991, the new nationwide registry was started. Definition and documentation were based on the Japanese Classification of Gastric Carcinoma, 11th edition [2] . The data list is shown in Table 1 . Data of patients treated in 1991 were collected in 1998-1999 because 5-year follow-up data and the causes of death were requested to be reported. Names of patients and other personal data were removed from the data for privacy protection. The 3.5″ floppy disks containing the data were mailed to the data center located in the National Cancer Center Hospital, Tokyo.
Eventually, data from 8851 patients were collected from 113 hospitals. Of these, 305 patients were excluded because of the final diagnosis as a recurrence in the gastric remnants, or histological diagnosis of other malignant tumors such as malignant lymphoma or leiomyosarcoma. Data of 238 patients were also excluded because of lack of essential data. Data from the remaining 8308 patients with primary gastric carcinoma underwent the final statistical analysis. The cumulative 5-year survival rate (5YSR) was calculated for various subsets of patients. Any types of death observed during 5 postoperative years, including direct death, or death due to other cancer or other diseases, were reflected in the survival analysis. Causes of death were also reported.
In this report, the data were translated into the 2nd English edition of the Japanese Classification of Gastric Carcinoma [3] , published in 1998, to facilitate international understanding. Although the UICC TNM Classification, 4th edition [4] , published in 1987, was designed using the same principle as the Japanese classification, the latter was more detailed in several categories. The Japanese T-category and staging system were compatible with the TNM classification. Peritoneal metastasis and liver metastasis were separately recorded in the Japanese classification as P-and H-categories, but they could easily be translated into the M-category in the TNM classification. The N-category was the most problematic for translation because the Japanese was based on the anatomical lymphatic streams and extension of node metastasis in association with location of the primary tumor, while the N category in the TNM classification was 4th edition also adopted the anatomical extension of node metastasis but not strictly based on lymph node (LN) stations as defined by the Japanese classification. Survival data stratified by TNM stage in this report should therefore be considered as preliminary.
The following data by important categories were shown on each table: total number of patients, direct death within 30 postoperative days, lost to follow-up, cumulative survival rates by year, 5% standard difference of 5YSR, number of alive patients at 5th postoperative year, causes of death such as local recurrence including lymph node metastasis, peritoneal recurrence, liver recurrence, distant metastasis excluding peritoneal and liver recurrence, recurrence of unknown site, other cancer, other disease, cause of death unknown. Cumulative survival curves of essential categories are also shown in Figs. 1-9. Definitions used in the Japanese Classification of Gastric Carcinoma, 11th edition, are briefly explained in the footnotes with reference to the 2nd English edition.
Results
Of the 8308 patients, 7935 underwent gastric resection, and the resection rate was 95.5%. Eighty-seven patients died within 30 days of surgery, and the direct death rate was 1.0% (87/8308). The number of patients who were lost to follow-up was 571, and the percentage was 6.9% (Table 2) .
For patients treated by gastric resection, the most frequent cause of death was peritoneal recurrence (n = 737) followed by other diseases (n = 390), local recurrence including node metastasis (n = 318), liver metastasis (n = 318), recurrence of unknown site (n = 266), distant metastasis other than the peritoneum and liver (n = 108), and secondary cancer (n = 104), while the cause of death was unknown in 131 patients (Table 2) .
A high incidence of early-stage cancer is the major characteristic of this series, and the proportion of pT1 was 48.8% (3871/7935). The 5YSR of this population was 90.4% (Table 13 ). It was noteworthy that their primary cause of death was not cancer recurrence (n = 84) but other diseases (n = 161). A large proportion of patients (58.1%) had a stage-I disease by the Japanese classification, with the 5YSR of 89.9%. Stage IV was found among 15.1% of the series, with a poor 5YSR of 9.0% (Table 38) .
The proportion of upper-third cancer was 20.8% (1652/7935), and its 5YSR was relatively low at 57.1%, The 5YSR of patients with esophageal invasion was even lower, at 33.4% (Table 7) .
As for the histopathological type, poorly differentiated carcinoma (5YSR was 59.0% for solid type and 55.5% for nonsolid type) and mucinous carcinoma (5YSR: 49.7%) showed poorer prognosis (Table 20) . Also carcinoma with scirrhous type stroma (5YSR: 47.2%), strong infiltrating growth or INF γ, (5YSR: 47.5%), marked lymphatic invasion or ly3, (5YSR: 24.7%), and severe venous invasion or v3, (5YSR: 23.5%) were other histopathological signs of poor prognosis (Tables 21-25). D2 lymph node dissection was most commonly performed (n = 5366, 67.6%) and its 5YSR was 73.9%. Almost 10% of the series (783/7935) were treated by more extended node dissection, dissecting lymph nodes along the hepatoduodenal ligament (D3) and paraaortic region (D4). 5YSR of this subset was 51.2% and was poorer than that of D2. The result most likely reflects the generally advanced stage of the patients (Table 34) . For pT2 cancer, 5YSR was higher among patients receiving systematic LN dissection (D2-D4) (68.4%) than in those with limited dissection (D0 or D1) (40.6%) (Tables 14, 15). Likewise, patients treated with systematic lymphadenectomy had higher 5YSR than those treated with limited dissection for pT3 cancer (39.0% versus 8.0%) (Tables 14, 15). Similarly in patients with pN1 metastasis, D2-D4 dissection showed better survival (5YSR: 62.3%) to D0 or D1 (5YSR: 33.1%) (Tables 27, 28).
The proportion of patients treated by combined resection of neighboring organs was 30.2% (2394/7935), and the 5YSR was 49.3% (Table 35 ). The proportion of total gastrectomy was 30.7% (2439/7935), and its 5YSR was 49.2% (Table 32) .
The curative potential of resection was an important prognostic factor. The number of patients with a high probability of cure (curability A) was 4959 (proportion: 62.5%), and its 5YSR was 88.5%. On the other hand, patients with definite residual tumor (curability C) was 1235 (proportion: 15.6%), and its 5YSR was 6.5% (Table 37) .
Discussion
The data presented in this report were collected from 113 leading hospitals in Japan. The number of new pa-tients with gastric cancer in 1991 was estimated to be approximately 100 000; thus the patients registered in this study (n = 8308) correspond to 8.3% of the total new patients. However, the data may not be suitable to use for epidemiological studies because they represent gastric cancer diagnosed and treated at specialized centers.
The findings were recorded based on the 11th edition of the Japanese Classification of Gastric Carcinoma (published in 1985). For international understanding, the registration committee tried to translate the data for the 2nd English edition of the Japanese classification (1998) and the 4th edition of the UICC TNM classification (1987) . All data except the N-category were completely translatable. However, several considerations were necessary in translating the N-category. For example, regional LN stations, classified into four compartments (N1-N4) in the 11th Japanese edition, were reclassified into three compartments (N1-N3) in the 2nd English edition. Consequently, metastases to the para-aortic nodes, classified as N4 in the 11th Japanese edition, are now included in N3 in the 2nd English edition. In this article, patients with N3 and N4 status according to the Japanese classification 11th edition and those treated by D3 or D4 dissection were analyzed together, and these groups were designated as N3 + N4 and D3 + D4.
The predominance of early-stage cancer with excellent survival, relative rarity of proximal cancer, and a high percentage of patients undergoing D2 and extended D3 + D4 dissection are among some features of this population that may seem strikingly different from the situation in the West. From the viewpoint of morbidity associated with surgery, it is important to note that combined resection of the pancreas was no longer a commonly performed procedure, 9.1% (726/7935). Locoregional recurrence was not a common pattern of disease failure in this population, and this may reflect the effect of D2 dissection in terms of local control. However, differences in survival between the D2-D4 group and the limited surgery (D0, D1) group for pT2, pT3, and pN1 cancers may need some explanation. Death due to other diseases was observed in 10% (25/ 239) of patients with pT2 cancer treated by limited surgery as compared with 4.3% (74/1714) in those treated with D2-D4 lymphadenectomy, and there is a possibility that limited lymphadenectomy had been selected for patients with co-morbidity who were destined to have a poor outcome. Peritoneal recurrence was observed among 37.7% (119/316) of pT3 cancer treated with limited surgery versus 22.6% (288/1274) treated with D2-D4. There is a possibility that limited surgery might be selected for patients who had concomitant peritoneal seeding and nevertheless underwent gastrectomy. To clarify the survival benefit of systematic LN dissection (D2-D4), we are now planning a multivariate analysis using the series. The stomach is anatomically divided into three portions. If more than one portion is involved, all involved portions should be described in order of degree of involvement. Namely, the first letter indicates the portion in which the bulk of the tumor is situated, and the portion is used for categorization in Table 7 .
Footnote for Dissection of all the N1 nodes D2:
Dissection of all the N1 and N2 nodes D3:
Dissection of all the N1, N2, and N3 nodes Dissection of para-aortic LNs was classified as "D4" in the 12th edition. These procedures are now included in D3. D3 and D4 were called as "extended LN dissection" and D2-D4 were called as "systematic LN dissection." Tables 38-41 : Japanese staging in the 12th Japanese edition [5] Japanese staging, 11th ed., was not correlated with survivals. To remove the contradiction, Japanese staging, 12th ed., was published in 1993, and it was principally the same as UICC-TNM staging, 5th ed. For the continuity of statistics, this analysis used the Japanese staging, 12th ed. As the staging was evaluated by a combination of T, N, and M, it was possible to recalculate the Japanese staging, 12th ed., from the collected data (see table at right). The UICC-TNM staging, 5th ed., could also be recalculated. N0  N1  N2  N3  <N2  N3/N4   T1  IA  IB  II  IIIA   T2  IB  II  IIIA IIIB  IVA   T3  II  IIIA IIIB IVA   T4  IIIA 
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